William Demant Foundation is the majority owner of Demant A/S (55-60%) through William Demant Invest A/S, which is the 100% owned holding company for William Demant Foundation’s investment activities.
In addition to Demant A/S, William Demant Invest A/S holds the majority ownerships of the orthopedics company Össur hf. (52% ownership) and Vision RT Ltd., which develops camera systems for surface-guided radiation therapy (89% ownership). Moreover, William Demant Invest A/S is the largest shareholder in Vitrolife AB, CellaVision AB and Revenio Oyj, which are engaged in developing medical equipment for fertility treatment, blood cell analysis and diagnosis of eye diseases, respectively. William Demant Invest A/S holds between 10% and 30% of the shares in these companies. Finally, William Demant Invest A/S is the largest shareholder in the listed real estate and service company Jeudan A/S (42% ownership) and owns together with KIRKBI A/S 50% of the German offshore wind farm, Borkum Riffgrund 1. Össur hf. and Jeudan A/S are listed in Denmark, while Vitrolife AB and CellaVision AB are listed in Sweden and Revenio Oyj is listed in Finland.